Indian Pharmaceuticals & Biotech Upcoming Dividends

Abbott India

Market Cap: ₹591.2b

Operates as a pharmaceutical company in India.

Dr. Reddy's Laboratories

Market Cap: ₹1.1t

Operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally.

Sanofi India

Market Cap: ₹72.9b

Manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.

Pfizer

Market Cap: ₹213.7b

Engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally.

Caplin Point Laboratories

Market Cap: ₹154.2b

Engages in the development, production, marketing, and export of generic formulations and branded products in India.

Jenburkt Pharmaceuticals

Market Cap: ₹5.1b

Researches and develops, manufactures, and markets pharmaceutical and healthcare products in India.

GlaxoSmithKline Pharmaceuticals

Market Cap: ₹391.3b

Manufactures, distributes, and trades in pharmaceuticals in India and internationally.

Cipla

Market Cap: ₹1.1t

Manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally.

Vimta Labs

Market Cap: ₹20.2b

Provides contract research and testing services in India and internationally.

Granules India

Market Cap: ₹186.2b

Manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationally.

Smruthi Organics

Market Cap: ₹1.4b

Manufactures and markets active pharmaceutical ingredient (API) products to India.

Syngene International

Market Cap: ₹183.9b

A contract research and manufacturing company, provides drug discovery and development services in India, the United States of America, Europe, and internationally.

Gland Pharma

Market Cap: ₹384.5b

Engages in manufacturing and sale of injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and internationally.